Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Revelation Biosciences, Inc. (REVB)

Aptevo Therapeutics Inc. and Revelation Biosciences, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and Revelation Biosciences, Inc. are of similar size ($3.1M and $3.0M). Revelation Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Across the 9 metrics below, Aptevo Therapeutics Inc. leads on 5 and Revelation Biosciences, Inc. on 4.

Valuation

Metric APVO REVB Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.15 n/m 9.71
P/B 0.32 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.86 0.64
EV/Sales (0.34) n/m 9.21
Earnings yield 100,773.33% (2,564.58%) (33.15%)
Free cash flow yield (1,315.16%) (513.59%) (25.50%)

Profitability

Metric APVO REVB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (276.43%) (56.36%)
Return on assets (186.29%) (214.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO REVB Biotechnology median
Revenue growth (TTM) 92.94% — 6.02%
EPS growth (last fiscal year) 99.72% 97.72% 30.26%
Revenue growth, 5-year CAGR (26.64%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 6.21 4.72
Net debt to EBITDA 0.83 1.18 0.96

Dividend

Metric APVO REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO REVB Biotechnology median
Market cap 3.08m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack